Peter Mueller
2012
In 2012, Peter Mueller earned a total compensation of $3.6M as EVP, Global R&D Chief Scientific Officer at Vertex Pharmaceuticals, a 8% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $418,296 |
|---|---|
| Option Awards | $2,036,301 |
| Salary | $598,980 |
| Stock Awards | $548,863 |
| Other | $12,450 |
| Total | $3,614,890 |
Mueller received $2M in option awards, accounting for 56% of the total pay in 2012.
Mueller also received $418.3K in non-equity incentive plan, $599K in salary, $548.9K in stock awards and $12.5K in other compensation.
Rankings
In 2012, Peter Mueller's compensation ranked 1,873rd out of 11,487 executives tracked by ExecPay. In other words, Mueller earned more than 83.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,873 out of 11,487 | 84th |
Division Manufacturing | 675 out of 4,252 | 84th |
Major group Chemicals And Allied Products | 153 out of 1,200 | 87th |
Industry group Drugs | 86 out of 922 | 91st |
Industry Pharmaceutical Preparations | 71 out of 697 | 90th |
Source: SEC filing on March 28, 2014.
Mueller's colleagues
We found six more compensation records of executives who worked with Peter Mueller at Vertex Pharmaceuticals in 2012.
2012
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2012
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2012
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2012
David Howton
Vertex Pharmaceuticals
Chief Legal Officer
2012
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2012
Kenneth Horton
Vertex Pharmaceuticals